Well that was much ado about nothing.
There is nothing in the annual report that suggests progress since the half-year report. Which means either:
1. there really has been no progress with the trials; or
2. IMU management should spend less time making embarrassing videos and more time learning how to report progress.
All the indicative timeframes for trial completions have been removed - which can only mean delays.
Not a single figure regarding patient recruitment. Why? How many of the 68 patients for the HER-Vaxx trial have been recruited? When does the company expect the first of the 30 patients for the PD1-Vaxx trial to be enrolled? When does the company expect the first recruit to the CF33 trial? Same with Vaxinia.
Too much back-patting on the company having $30m in the bank (old news anyway) and not enough criticism of the poor progress reporting.
- Forums
- ASX - By Stock
- IMU
- Ann: Appendix 4E & Annual Report to shareholders
Ann: Appendix 4E & Annual Report to shareholders, page-21
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.6¢ |
Change
-0.004(6.67%) |
Mkt cap ! $411.5M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.5¢ | $1.481M | 26.09M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 400000 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 685507 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 400000 | 0.056 |
34 | 4259093 | 0.055 |
21 | 3126330 | 0.054 |
23 | 3881412 | 0.053 |
17 | 1361472 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 685507 | 4 |
0.058 | 536198 | 4 |
0.059 | 472079 | 4 |
0.060 | 766014 | 9 |
0.061 | 1058769 | 7 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online